Rybelsus
Rybelsus is an oral tablet form of semaglutide for type 2 diabetes management.
Patient-Friendly Explanation
Rybelsus is a daily tablet version of semaglutide for people with type 2 diabetes. It offers an oral alternative to injections.
Clinical Definition
Rybelsus is the first oral GLP-1 receptor agonist, containing semaglutide with an absorption enhancer. It is indicated for type 2 diabetes at doses of 3 mg, 7 mg or 14 mg daily. It is a prescription-only medicine.
This library is for general education and does not replace individual assessment by a qualified healthcare professional. Always consult a doctor for medical advice, diagnosis, or treatment.
Ready to Start Your Journey?
Book a Free Weight Management Consultation with our doctor today.
Book Free Consultation →